Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123018 · ClinicalTrials.gov registry record
Screening for Memory Studies
A clinical trial of Dementia and Memory Loss, sponsored by John Wesson Ashford Jr.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01123018 is a study of Dementia and Memory Loss that is active but no longer recruiting, run by John Wesson Ashford Jr. The registered enrollment target is 2,000 participants, below the 7,713-participant average among 199 other Dementia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01123018, a study of Dementia and Memory Loss, is active but no longer recruiting, sponsored by John Wesson Ashford Jr.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
We hope to recruit participants into various clinical trials and research projects.
Conditions Studied
Interventions
- BEHAVIORAL Memtrax Memory screening test
Study Locations (1)
California
- VA Palo Alto Health Care System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2007-06 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123018
The ClinicalTrials.gov registry entry for NCT01123018 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,713-participant average among 199 other Dementia trials with a reported enrollment target (74% lower). The listed sponsor is John Wesson Ashford Jr, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Memtrax Memory screening test is the first listed.
NCT01123018 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01123018 about?
NCT01123018 is a clinical study titled "Screening for Memory Studies". We hope to recruit participants into various clinical trials and research projects.
What is the current status of trial NCT01123018?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2007-06. Estimated completion is 2029-12.
What conditions does trial NCT01123018 study?
This clinical trial studies the following conditions: Dementia, Memory Loss, Memory Deficits.
What interventions are being tested in trial NCT01123018?
The interventions under investigation include: Memtrax Memory screening test (BEHAVIORAL).
Who is sponsoring clinical trial NCT01123018?
This trial is sponsored by John Wesson Ashford Jr, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01123018 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.